Literature DB >> 22624958

Chronic inflammation as predictor of 1-year hospitalization and mortality in elderly population.

David de Gonzalo-Calvo1, Beatriz de Luxán-Delgado, Pablo Martínez-Camblor, Susana Rodríguez-González, Marina García-Macia, Francisco M Suárez, Juan J Solano, María J Rodríguez-Colunga, Ana Coto-Montes.   

Abstract

BACKGROUND: Systemic low-grade inflammation is thought to be associated with an increased risk of adverse clinical outcomes in elderly population. We tested this notion with the goal of identifying useful potential biomarkers of 1-year hospitalization and mortality in the elderly population.
DESIGN: A total of 120 institutionalized older subjects were enrolled as participants in this study, including 90 women and 30 men (ranging in age from 68 to 105 years), selected from Santa Teresa nursing home (Oviedo, Spain). We studied functional status, morbidity, socio-demographic characteristics and several inflammation and inflammation-related markers.
RESULTS: The study included 95 non-hospitalized participants and 23 participants with at least one hospitalization during 1 year (19% of subjects). The study also included 100 survivors and 19 participants who died during the 1-year study (16% of subjects). In logistic regression models adjusted by age, sex, anti-inflammatory drug use and morbid conditions, high levels of interleukin 1 receptor antagonist (IL-1ra) and red blood cell distribution width (RDW) were associated with hospitalization and death at 1 year. Elevated levels of tumour necrosis factor α (TNF-α) were also associated with an increased risk of death at 1 year after adjusting for the same potential confounders. Multivariate logistic regression models showed that elevated serum levels of IL-1ra were intimately associated with 1-year subsequent hospitalization and mortality in aged subjects after adjusting for age, sex, anti-inflammatory drug use and morbid conditions.
CONCLUSIONS: Current data suggest that IL-1ra is a predictor of 1-year hospitalization and mortality in the elderly population.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624958     DOI: 10.1111/j.1365-2362.2012.02689.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Associations of the antioxidant capacity and hemoglobin levels with functional physical performance of the upper and lower body limbs.

Authors:  Beatriz Caballero; Adrián Rubio-González; Yaiza Potes; Marta Martínez-Reig; Pedro Manuel Sánchez-Jurado; Luis Romero; Juan José Solano; Pedro Abizanda; Ana Coto-Montes
Journal:  Age (Dordr)       Date:  2014-01-03

2.  Stability in BMI over time is associated with a better cognitive trajectory in older adults.

Authors:  Michal Schnaider Beeri; Amir Tirosh; Hung-Mo Lin; Sapir Golan; Ethel Boccara; Mary Sano; Carolyn W Zhu
Journal:  Alzheimers Dement       Date:  2022-01-20       Impact factor: 16.655

3.  Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction.

Authors:  Netusha Thevaranjan; Alicja Puchta; Christian Schulz; Avee Naidoo; J C Szamosi; Chris P Verschoor; Dessi Loukov; Louis P Schenck; Jennifer Jury; Kevin P Foley; Jonathan D Schertzer; Maggie J Larché; Donald J Davidson; Elena F Verdú; Michael G Surette; Dawn M E Bowdish
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

4.  Effects of microbiota-driven therapy on inflammatory responses in elderly individuals: A systematic review and meta-analysis.

Authors:  Hua Qu; Ying Zhang; Hua Chai; Zhu-Ye Gao; Da-Zhuo Shi
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

Review 5.  Management of inflammatory rheumatic conditions in the elderly.

Authors:  Clément Lahaye; Zuzana Tatar; Jean-Jacques Dubost; Anne Tournadre; Martin Soubrier
Journal:  Rheumatology (Oxford)       Date:  2019-05-01       Impact factor: 7.580

6.  Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease.

Authors:  Takahiro Amano; Shinichiro Shinzaki; Akiko Asakura; Taku Tashiro; Mizuki Tani; Yuriko Otake; Takeo Yoshihara; Shuko Iwatani; Takuya Yamada; Yuko Sakakibara; Naoto Osugi; Shuji Ishii; Satoshi Egawa; Manabu Araki; Yuki Arimoto; Masanori Nakahara; Yoko Murayama; Ichizo Kobayashi; Kazuo Kinoshita; Hiroyuki Ogawa; Satoshi Hiyama; Narihiro Shibukawa; Masato Komori; Yorihide Okuda; Takashi Kizu; Shunsuke Yoshii; Yoshiki Tsujii; Yoshito Hayashi; Takahiro Inoue; Hideki Iijima; Tetsuo Takehara
Journal:  Sci Rep       Date:  2022-03-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.